搜索临床试验以:Apatinib Camrelizumab
总计2471个结果
-
Fudan UniversityShanghai Shen Kang Hospital Development Center招聘中
-
Lei Li招聘中宫颈癌 | 免疫疗法 | 生存结果 | 不良事件 | 局部晚期宫颈癌 | 放化疗 | 免疫检查点抑制剂 | 抗程序性细胞死亡受体 1 | Early Stage Cervical Cancer中国
-
The First Affiliated Hospital of Xiamen University尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Beijing HospitalJiangsu HengRui Medicine Co., Ltd.未知HER-2 Negatived Gastric Cancer中国
-
Zhejiang Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Zhejiang Cancer HospitalZhejiang Provincial People's Hospital; Jinhua Municipal Central Hospital; Huizhou Municipal Central... 和其他合作者尚未招聘
-
Eye & ENT Hospital of Fudan UniversityChinese Academy of Medical Sciences招聘中
-
Wei ZhaoCancer Institute and Hospital, Chinese Academy of Medical Sciences未知
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital撤销
-
Augusta UniversityH. Jean Khoury Cure CML Consortium招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Yue HanJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.完全的
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital...完全的
-
Second Affiliated Hospital, School of Medicine,...尚未招聘
-
Chinese PLA General Hospital未知
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
National Cancer Institute (NCI)主动,不招人转移性胰腺癌 | 复发性胰腺癌 | III 期胰腺癌 AJCC v6 和 v7 | IV 期胰腺癌 AJCC v6 和 v7美国
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceutical Co., Ltd.未知
-
Jiangsu HengRui Medicine Co., Ltd.招聘中